Biosafety Issues in Patient Transport during COVID-19: A Case Study on the Portuguese Emergency Services

Author:

Vandenberghe Pierre1,Ladeira Luis Manuel2ORCID,Gil Margarida2,Cardoso Ivo2,Rato Fatima2ORCID,Hayes Jessica S.3ORCID,Connolly Maire A.3,Gala Jean-Luc1ORCID

Affiliation:

1. Centre for Applied Molecular Technologies (CTMA), Institute for Clinical and Experimental Research (IREC), Université Catholique de Louvain, Tour Claude Bernard, Avenue Hippocrate, 54-55, bte B1.54.01, 1200 Bruxelles, Belgium

2. Instituto Nacional de Emergência Médica, Rua Almirante Barroso, 36, 1000-013 Lisboa, Portugal

3. School of Health Sciences, College of Medicine, Nursing and Health Sciences, University of Galway, H91 TK33 Galway, Ireland

Abstract

During the COVID-19 pandemic, first responders faced significant biosafety challenges, especially while handling patient transport, potentially exposing them to infection. The PANDEM-2 (European project on pandemic preparedness and response) project, funded by the Horizon 2020 program, sought to investigate the challenges confronting Emergency Medical Systems throughout the EU. First responders from Portugal’s National Institute of Medical Emergency (INEM) were considered as a representative operational model of the national first responder agencies of European member states because they played a critical role during the COVID-19 pandemic. As a result, they were asked to complete an online survey about their COVID-19 pandemic-related professional activities. The survey focused on their perspectives on current biosafety guidelines and their operational practices. It covered opinions on existing protocols, technical concerns during patient transport, and issues after the patients arrived at the hospital. The key findings revealed concerns about risk assessment, the inadequacy of guidelines, and disparities in equipment access. This survey emphasizes the importance of developing streamlined, adaptable biosafety protocols, better coordination between prehospital and in-hospital services, and the development of scalable, cost-effective biosafety solutions. Based on our findings, we propose improvements to national and European biosafety directives and advocate for streamlined adaptation during pandemics.

Funder

European Union’s Horizon 2020 Research and Innovation program

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3